Gujarat Inject Kerala Ltd will subdivide its shares 1:10, reducing face value from ₹10 to Re.1. The record date is July 2, 2026. This aims to boost liquidity and make shares more accessible.
Gujarat Inject Kerala Ltd to Subdivide Shares 1:10
Gujarat Inject Kerala Ltd will subdivide its equity shares in a 1:10 ratio. The face value will change from ₹10 per share to Re.1 per share.
Reader Takeaway: Stock split to enhance liquidity; record date July 2, 2026.
What just happened
Gujarat Inject Kerala Ltd's Board of Directors has confirmed the timeline for a stock split. Following shareholder approval, the company will divide each existing equity share of ₹10 face value into 10 shares of Re.1 face value each. This corporate action is set to occur with a record date of July 2, 2026.
Why this matters
A stock split, or sub-division, increases the number of shares available while proportionally lowering the price per share. This move is often undertaken to make the stock more affordable and accessible to a wider investor base, potentially improving trading liquidity.
The backstory
Gujarat Inject Kerala Ltd is a publicly listed company on Indian stock exchanges. Stock splits are common corporate actions aimed at adjusting the share price without altering the company's fundamental value or market capitalization. Shareholder approval was secured via an Ordinary Resolution at an Extra-Ordinary General Meeting.
What changes now
For existing shareholders, the number of shares held will multiply by 10, while the price per share will theoretically decrease by a factor of 10. The total value of their investment will remain the same immediately after the split. The change will be automatically reflected in their demat accounts.
Risks to watch
While stock splits can sometimes lead to increased investor interest, they do not inherently change the company's financial performance or future prospects. Investors should focus on the company's underlying business fundamentals rather than just the split itself.
Peer comparison
Many companies in various sectors, including pharmaceuticals and manufacturing, have undertaken stock splits in the past to manage share prices and improve liquidity. The specific impact depends on market perception and the company's operational performance.
Context metrics (time-bound)
- Event: Stock Split (Sub-division)
- Split Ratio: 1:10
- Existing Face Value: ₹10 per share
- Revised Face Value: Re.1 per share
- Record Date: July 2, 2026
What to track next
Investors should monitor the stock's price movement around the record date and its trading volume post-split to assess the impact on liquidity. Key financial results and company announcements will remain crucial for evaluating the investment.